• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NeuroD-β细胞素基因疗法可诱导肝脏中胰岛新生并逆转小鼠糖尿病。

NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice.

作者信息

Kojima Hideto, Fujimiya Mineko, Matsumura Kazuhiro, Younan Patrick, Imaeda Hirotsugu, Maeda Makiko, Chan Lawrence

机构信息

Section of Diabetes, Endocrinology & Metabolism, Departments of Medicine and Molecular & Cellular Biology, Baylor College of Medicine, Houston, Texas, USA.

出版信息

Nat Med. 2003 May;9(5):596-603. doi: 10.1038/nm867. Epub 2003 Apr 21.

DOI:10.1038/nm867
PMID:12704384
Abstract

To explore induced islet neogenesis in the liver as a strategy for the treatment of diabetes, we used helper-dependent adenovirus (HDAD) to deliver the pancreatic duodenal homeobox-1 gene (Ipf1; also known as Pdx-1) to streptozotocin (STZ)-treated diabetic mice. HDAD is relatively nontoxic as it is devoid of genes encoding viral protein. Mice treated with HDAD-Ipf1 developed fulminant hepatitis, however, because of the exocrine-differentiating activity of Ipf1. The diabetes of STZ mice was partially reversed by HDAD-mediated transfer of NeuroD (Neurod), a factor downstream of Ipf1, and completely reversed by a combination of Neurod and betacellulin (Btc), without producing hepatitis. Treated mice were healthy and normoglycemic for the duration of the experiment (>120 d). We detected in the liver insulin and other islet-specific transcripts, including proinsulin-processing enzymes, beta-cell-specific glucokinase and sulfonylurea receptor. Immunocytochemistry detected the presence of insulin, glucagon, pancreatic polypeptide and somatostatin-producing cells organized into islet clusters; immuno-electron microscopy showed typical insulin-containing granules. Our data suggest that Neurod-Btc gene therapy is a promising regimen to induce islet neogenesis for the treatment of insulin-dependent diabetes.

摘要

为了探索肝脏中诱导性胰岛新生作为治疗糖尿病的一种策略,我们使用了辅助依赖型腺病毒(HDAD)将胰腺十二指肠同源盒-1基因(Ipf1;也称为Pdx-1)导入经链脲佐菌素(STZ)处理的糖尿病小鼠体内。HDAD相对无毒,因为它不含编码病毒蛋白的基因。然而,由于Ipf1的外分泌分化活性,用HDAD-Ipf1处理的小鼠发生了暴发性肝炎。Ipf1下游的一个因子NeuroD(Neurod)经HDAD介导转移后,STZ小鼠的糖尿病得到部分逆转,而Neurod和β细胞ulin(Btc)联合使用则可使其完全逆转,且不会引发肝炎。在实验期间(>120天),经治疗的小鼠健康且血糖正常。我们在肝脏中检测到了胰岛素和其他胰岛特异性转录本,包括胰岛素加工酶、β细胞特异性葡萄糖激酶和磺脲类受体。免疫细胞化学检测到了组织成胰岛簇的胰岛素、胰高血糖素、胰多肽和生长抑素分泌细胞的存在;免疫电子显微镜显示出典型的含胰岛素颗粒。我们的数据表明,Neurod-Btc基因疗法是一种有前景的诱导胰岛新生以治疗胰岛素依赖型糖尿病的方案。

相似文献

1
NeuroD-betacellulin gene therapy induces islet neogenesis in the liver and reverses diabetes in mice.NeuroD-β细胞素基因疗法可诱导肝脏中胰岛新生并逆转小鼠糖尿病。
Nat Med. 2003 May;9(5):596-603. doi: 10.1038/nm867. Epub 2003 Apr 21.
2
Reversal of streptozotocin-induced diabetes in rats by gene therapy with betacellulin and pancreatic duodenal homeobox-1.通过β细胞ulin和胰腺十二指肠同源盒-1基因治疗逆转链脲佐菌素诱导的大鼠糖尿病
Gene Ther. 2007 Jul;14(14):1102-10. doi: 10.1038/sj.gt.3302963. Epub 2007 Apr 26.
3
Organ alchemy: producing insulin in the liver.器官炼金术:在肝脏中生产胰岛素。
Nat Med. 2003 May;9(5):504-5. doi: 10.1038/nm0503-504.
4
Neo-islet formation in liver of diabetic mice by helper-dependent adenoviral vector-mediated gene transfer.通过辅助依赖型腺病毒载体介导的基因转移在糖尿病小鼠肝脏中形成新胰岛。
J Vis Exp. 2012 Oct 10(68):4321. doi: 10.3791/4321.
5
Gene therapy with neurogenin3, betacellulin and SOCS1 reverses diabetes in NOD mice.采用神经生成素3、β细胞ulin和细胞因子信号转导抑制因子1进行基因治疗可逆转非肥胖糖尿病(NOD)小鼠的糖尿病症状。
Gene Ther. 2015 Nov;22(11):876-82. doi: 10.1038/gt.2015.62. Epub 2015 Jul 14.
6
Betacellulin improves glucose metabolism by promoting conversion of intraislet precursor cells to beta-cells in streptozotocin-treated mice.β细胞ulin通过促进链脲佐菌素处理的小鼠胰岛内前体细胞向β细胞的转化来改善葡萄糖代谢。
Am J Physiol Endocrinol Metab. 2003 Sep;285(3):E577-83. doi: 10.1152/ajpendo.00120.2003.
7
beta-cell neogenesis induced by adenovirus-mediated gene delivery of transcription factor pdx-1 into mouse pancreas.腺病毒介导的转录因子pdx-1基因传递至小鼠胰腺诱导β细胞新生
Gene Ther. 2003 Jan;10(1):15-23. doi: 10.1038/sj.gt.3301846.
8
Ectopic PDX-1 expression in liver ameliorates type 1 diabetes.肝脏中异位表达的胰腺十二指肠同源盒蛋白-1可改善1型糖尿病。
J Autoimmun. 2007 Mar-May;28(2-3):134-42. doi: 10.1016/j.jaut.2007.02.010. Epub 2007 Mar 23.
9
Adenovirus transduction is required for the correction of diabetes using Pdx-1 or Neurogenin-3 in the liver.在肝脏中使用Pdx-1或Neurogenin-3纠正糖尿病需要腺病毒转导。
Mol Ther. 2007 Feb;15(2):255-63. doi: 10.1038/sj.mt.6300032.
10
Induction of insulin and islet amyloid polypeptide production in pancreatic islet glucagonoma cells by insulin promoter factor 1.胰岛素启动因子1诱导胰岛胰高血糖素瘤细胞产生胰岛素和胰岛淀粉样多肽。
Proc Natl Acad Sci U S A. 1996 Aug 20;93(17):9015-20. doi: 10.1073/pnas.93.17.9015.

引用本文的文献

1
Preventing vision loss in a mouse model of Leber Congenital Amaurosis by engineered tRNA.通过工程化tRNA在莱伯先天性黑蒙小鼠模型中预防视力丧失
bioRxiv. 2025 Jul 11:2025.07.10.660754. doi: 10.1101/2025.07.10.660754.
2
Umbilical Cord-Mesenchymal Stromal Cell-Derived Extracellular Vesicles Target the Liver to Improve Neurovascular Health in Type 2 Diabetes With Non-Alcoholic Fatty Liver Disease.脐带间充质基质细胞衍生的细胞外囊泡靶向肝脏以改善伴有非酒精性脂肪性肝病的2型糖尿病患者的神经血管健康。
J Extracell Vesicles. 2025 Jul;14(7):e70125. doi: 10.1002/jev2.70125.
3
Gene Therapy and Diabetes: A Narrative Review of Recent Advances and the Role of Multidisciplinary Healthcare Teams.
基因治疗与糖尿病:近期进展及多学科医疗团队作用的叙述性综述
Genes (Basel). 2025 Jan 20;16(1):107. doi: 10.3390/genes16010107.
4
Traditional and emerging strategies using hepatocytes for pancreatic regenerative medicine.利用肝细胞进行胰腺再生医学的传统和新兴策略。
J Diabetes. 2024 Apr;16(4):e13545. doi: 10.1111/1753-0407.13545.
5
Global research trends of diabetes remission: a bibliometric study.全球糖尿病缓解研究趋势:文献计量研究。
Front Endocrinol (Lausanne). 2023 Nov 28;14:1272651. doi: 10.3389/fendo.2023.1272651. eCollection 2023.
6
Emerging therapeutic options in the management of diabetes: recent trends, challenges and future directions.新兴的糖尿病治疗选择:最新趋势、挑战与未来方向。
Int J Obes (Lond). 2023 Dec;47(12):1179-1199. doi: 10.1038/s41366-023-01369-3. Epub 2023 Sep 11.
7
Bone morphogenetic protein-7 attenuates pancreatic damage under diabetic conditions and prevents progression to diabetic nephropathy via inhibition of ferroptosis.骨形态发生蛋白 7 通过抑制铁死亡减轻糖尿病状态下的胰腺损伤并防止其进展为糖尿病肾病。
Front Endocrinol (Lausanne). 2023 May 24;14:1172199. doi: 10.3389/fendo.2023.1172199. eCollection 2023.
8
PDX-1: A Promising Therapeutic Target to Reverse Diabetes.PDX-1:逆转糖尿病的有前途的治疗靶点。
Biomolecules. 2022 Nov 30;12(12):1785. doi: 10.3390/biom12121785.
9
Differentiation of Human Adipose-Derived Mesenchymal Stromal/Stem Cells into Insulin-Producing Cells with A Single Tet-Off Lentiviral Vector System.利用单一四环素调控慢病毒载体系统将人脂肪间充质基质/干细胞分化为胰岛素分泌细胞
Cell J. 2022 Dec 1;24(12):705-714. doi: 10.22074/cellj.2022.557533.1063.
10
Reprogramming-Evolving Path to Functional Surrogate β-Cells.重编程——功能性替代β细胞的进化之路。
Cells. 2022 Sep 8;11(18):2813. doi: 10.3390/cells11182813.